| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c491d9293b8310179efca603a90298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afa08f39a7a232b611b59fa3dad21e39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62ebad13ef8895ac0b496417eeed5cb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_659c9df6d1d3daa636fc8f22b29aab15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09b0b0bee03fbb01384aa35ca6e0583b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 |
| filingDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3808e73fa021fbd13a0b2e3fc012b012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02665b1f02c855284100986a7b5cc6f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534be0b69267e5eba6b282000cf49b13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06c387b5cbe5aa869851c2ff3364ce01 |
| publicationDate |
2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005062985-A8 |
| titleOfInvention |
Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
| abstract |
The present invention is related to 10,20-di-O ester derivatives of camptothecin and pharmaceutical formulations thereof. The compounds and pharmaceutical formulations of the present invention possess increased biological life span and bioavailbility and reduced toxicity, while maintaining anti-cancer activity. |
| priorityDate |
2003-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |